Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT05869227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05869227
- Sponsor
- XIANG YANQUN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2027-12-20
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.